Lithium clearance: modification by the loop of Henle in man

Area of Science:

• Nephrology
• Renal Physiology
• Pharmacology

Background:

• Lithium clearance (CLi) is influenced by renal reabsorption.
• Understanding lithium reabsorption mechanisms in the loop of Henle is crucial for managing lithium therapy and renal function.

Purpose of the Study:

• To investigate the contribution of the loop of Henle to lithium reabsorption.
• To elucidate the specific mechanisms involved in lithium (Li+) reabsorption within the loop of Henle.
• To assess the impact of salt balance on lithium reabsorption.

Main Methods:

• Assessed lithium clearance (CLi) and fractional lithium clearance (FELi) in healthy volunteers under varying hydration and salt intake conditions.
• Administered bumetanide and acetazolamide to evaluate their effects on FELi and identify transporter involvement.
• Manipulated corticomedullary osmolal concentration gradients via fluid restriction and water loading.

Main Results:

• Alterations in corticomedullary osmolal gradients did not significantly affect CLi or FELi, suggesting minimal passive reabsorption in thin limbs.
• Increasing plasma Li+ showed only small reductions in CLi and FELi, indicating limited reabsorption via the Na+, K+, 2Cl- transporter.
• Bumetanide and acetazolamide significantly increased FELi, pointing to a bumetanide-sensitive mechanism in the loop of Henle.
• Acetazolamide-induced increases in tubular flow reduced bumetanide's effect on FELi, supporting a flow-dependent, paracellular mechanism in the thick ascending limb.

Conclusions:

• Lithium reabsorption in the loop of Henle occurs via a bumetanide-sensitive, flow-dependent, voltage-driven paracellular pathway in the thick ascending limb.
• Approximately 10-20% of filtered lithium is reabsorbed in the loop of Henle, varying with salt status.
• This mechanism explains the differences in lithium reabsorption observed between low and high salt intake conditions.